MET Exon 14 (Deletion)
Therapeutic response
Precision oncology relationships for therapeutic response involving this biomarker.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (2) HC (1) | MET Exon 14 (Deletion) | Non-Small Cell Lung Cancer | Capmatinib | |
| FDA (2) HC (1) | MET Exon 14 (Deletion) | Non-Small Cell Lung Cancer | Tepotinib |